App-Quantinova.ai

Resistant Graves’ thyrotoxicosis with adverse cardiovascular effects

Scott Williams - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ventricular arrhythmias

Levothyroxine

A case of severe thyrotoxicosis in acute setting presenting with hypercalcemia and deranged liver function test

Kirtanya Ramachandran - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Thyrotoxicosis

Prednisolone

Radioactive iodine treatment in thyrotoxicosis- audit, Southampton general hospital

Mohammed Salloum - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hyperthyroidism

Methadone hydrochloride

Rare presentation of thyrotoxicosis post CoVID-19 vaccination in acute setting

Megha Mohan - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Rheumatoid arthritis

Hydrocortisone

Immune check point inhibitors- induced thyroid disorders -would you recognise them?

Jegadeshwaran Gandhi - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Lung Cancer

Levothyroxine

Sub acute thyroiditis following COVID-19 vaccination – case report and International survey

William Bennet - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Subacute thyroiditis

Glucocorticoid

Outcomes of incidental thyroid nodules identified during imaging for primary hyperparathyroidism: a retrospective observational clinical study

Quratulain Yousuf - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Primary hyperparathyroidism

Technetium (99mTc) sestamibi

Glycogen hepatopathy - a case series

Bhavna Sharma - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Diabetic ketoacidosis

Alpha 1-Antitrypsin

Polyglandular autoimmune syndrome in the elderly: a case report

Sindhuja Suresh - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Autoimmune Thyroid Disease

Cyanocobalamin

Immunotherapy induced hypopituitarism including hypogonadism in patient with previous PCOS: call for early detection and endocrine work-up

Gesa Tiemeier - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Metastatic Renal Cell Cancer

Hydrocortisone

Central diabetes insipidus from a patients′ perspective – from management to psychological co-morbidities and re-naming of the condition

Cihan Atila - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Neurohypophyseal diabetes insipidus

vasopressin Injection

Discordant thyroid function tests following Ibrutinib therapy

Alwyn Yung Zhuang Choo - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Chronic kidney disease

Lyothyronine

Primary hyperparathyroidism, familial hypocalciuric hypercalcaemia or both?

Ashutosh Kapoor - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary hyperparathyroidism

Parathyroid hormone

Actions taken for prevention of adrenal insufficiency in adult patients who are at risk - audit report

Jayamalee Jayaweera - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Addison's disease

N/A

A case of ChAdOx1 vaccine-induced thrombocytopaenia and thrombosis syndrome leading to bilateral adrenal haemorrhage and adrenal insufficiency

Agathoklis Efthymiadis - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Immune thrombocytopenia

Fludrocortisone

Adrenal sarcomas – Exceptionally rare or more common than thought? Prevalence in adrenalectomy specimens over 12 months period and presenting features.

Nur Azman - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Adrenal carcinoma

Paclitaxel

Rare case of SIADH related hyponatremia in sarcoidosis

Bhavna Sharma - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sarcoidosis

furosemide GR

Single centre experience of assessment of adrenal incidentalomas – it’s time for a change

Thin Kyi Phyu Naing - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Adrenal carcinoma

N/A

Giant non-functioning adrenocortical carcinoma – the elephant in the room

Sing Yang Sim - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Adrenal carcinoma

Dexamethasone

Morning cortisol and circulating inflammatory cytokine levels: a mendelian randomisation study

Skanda Rajasundaram - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Glucocorticoid

Filters

45280 Abstracts